01 6APOTEX INC
02 6AURO PHARMA INC
03 6LABORATOIRE RIVA INC.
04 6MINT PHARMACEUTICALS INC
05 6NORA PHARMA INC
06 8OTSUKA PHARMACEUTICAL CO LTD
07 6PHARMASCIENCE INC
08 6PRO DOC LIMITEE
09 15Pharmascience Inc.
10 6SANDOZ CANADA INCORPORATED
11 6SANIS HEALTH INC
12 6SIVEM PHARMACEUTICALS ULC
01 68ARIPIPRAZOLE
02 15Aripiprazole
01 2POWDER FOR SUSPENSION, SUSTAINED-RELEASE
02 81TABLET
01 6ABILIFY
02 2ABILIFY MAINTENA
03 6APO-ARIPIPRAZOLE
04 18ARIPIPRAZOLE
05 6AURO-ARIPIPRAZOLE
06 6MINT-ARIPIPRAZOLE
07 6NRA-ARIPIPRAZOLE
08 6PMS-ARIPIPRAZOLE
09 6RIVA-ARIPIPRAZOLE
10 6SANDOZ ARIPIPRAZOLE
11 15Blank
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic Dossiers Under Development For EU
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Canada
LOOKING FOR A SUPPLIER?